How getting an early start with CDMOs can speed up commercialization



Pharmaceutical companies have much to gain by collaboration with the right CDMO (Contract Development & Manufacturing Organization) partners.

It’s no secret that properly executed commercialization is essential to the success of a new

product.


D2 provides contract development and manufacturing services from North American-based, FDA-compliant facilities.


If you have developed a biological product and don’t have the physical infrastructure to

perform manufacturing in-house, D2 has a solution! D2 has a strong history of aligning developers with good CDMO partners that match your manufacturing requirements from the beginning to help scale up the manufacturing of your product. Key benefits include no wasted time and significant reduction of risk associated with commercialization, as our CDMO partners have been well vetted and performed for other customers.


As a new product is introduced to the public during the commercialization stage, much of the potential for success or failure lies in the hands of the manufacturer. Though marketing and sales personnel play a vital role in bringing a new drug to market, quality, uninterrupted

production is undeniably the most important piece of a successful product launch. We have

developed a checklist that is utilized to manage the process. We have been successfully

matching pharmaceutical companies with CDMOs for years in the following areas:

  •  Sterile Injectables

  •  Oral Solids

  •  Ophthalmics

  •  Nasal Sprays

  •  Aerosols

  •  Topicals

  •  Oral Solutions

Regardless of your product, we handle the entire checklist for you, so you can focus on what you do best. It’s easy to get started. Contact us or email ( brian.sommer@d2rx.com) for more information.


8 views0 comments

Recent Posts

See All